Amgen "outperform," target price reduced

06.03.07 - Bear Stearns

NEW YORK, March 6 (newratings.com) - In a research note published yesterday, analysts at Bear Stearns reiterate their "outperform" rating on Amgen (AMGN). The target price has been reduced from $83 to $77.